Search results
Results from the WOW.Com Content Network
The mini–mental state examination (MMSE) or Folstein test is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. [1] [2] It is commonly used in medicine and allied health to screen for dementia. It is also used to estimate the severity and progression of cognitive impairment and ...
The mental status examination (MSE) is an important part of the clinical assessment process in neurological and psychiatric practice. It is a structured way of observing and describing a patient's psychological functioning at a given point in time, under the domains of appearance, attitude, behavior, mood and affect, speech, thought process, thought content, perception, cognition, insight, and ...
The negative predictive value for the total sample was 0.93 making it a good tool to rule out cognitive impairment. On all measures the GPCOG performed at least as well as the mini–mental state examination (MMSE). [1] [2] Of note, positive and negative predictive values depend on the prevalence of the disorder in the studied population.
The Addenbrooke's Cognitive Examination [2] was originally developed as a theoretically motivated extension of the mini–mental state examination (MMSE) [3] which attempted to address the neuropsychological omissions and improve the screening performance of the latter. [4]
Serial sevens (or, more generally, the descending subtraction task; DST), where a patient counts down from one hundred by sevens, is a clinical test used to test cognition; for example, to help assess mental status after possible head injury, in suspected cases of dementia or to show sleep inertia.
The IQCODE has found to correlate highly with conventional dementia screening tests, such as the Mini-Mental State Examination, and to have moderate correlations with a range of neuropsychological tests. It has also been found to correlate with change in cognitive test scores over time. [3]
The Montreal Cognitive Assessment (MoCA) is a widely used screening assessment for detecting cognitive impairment. [1] It was created in 1996 by Ziad Nasreddine in Montreal, Quebec. It was validated in the setting of mild cognitive impairment (MCI), and has subsequently been adopted in numerous other clinical settings. This test consists of 30 ...
Pages in category "Cognitive impairment and dementia screening and assessment tools" The following 14 pages are in this category, out of 14 total. This list may not reflect recent changes .